Malin Corporation

company

About

Malin Corporation plc is an Irish incorporated public limited company whose head office is in Dublin.

  • Dublin,Dublin,Ireland
  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€50M
Industries
Biotechnology,Life Science
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Malin Corporation Plc
Investor Type
Venture Capital

Malin Corporation plc (“Malin”) is an Irish incorporated public limited company whose head office is in Dublin, Ireland with subsidiary offices in New Haven, Connecticut and Research Triangle, North Carolina, USA.


Malin’s purpose is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-IPO, pre-trade sale operating businesses in dynamic and fast growing segments of the life sciences industry. Through its operational involvement, Malin works with its investee companies to enable them to reach the full potential of their value proposition and to achieve commercial success.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€50M
Malin Corporation has raised a total of €50M in funding over 2 rounds. Their latest funding was raised on Mar 1, 2015 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 1, 2015 Series Unknown €50M 1 Ireland Strategic Investment Fund Detail

Investments

Number of Investments
Number of Lead Investments
14
8
Malin Corporation has made 14 investments. Their most recent investment was on Nov 15, 2022, when CG Oncology raised $120M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 15, 2022 CG Oncology
Series E $120M Biotechnology
Series C $142M Biopharma
Series B $30.50M Biopharma
Series A $11.16M Biopharma Yes
Feb 24, 2017 Xenex
Series Unknown $38M Health Care

Investors

Number of Lead Investors
Number of Investors
1
1
Malin Corporation is funded by 1 investors. Ireland Strategic Investment Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Ireland Strategic Investment Fund Yes Series Unknown

Employee Profiles

Number of Employee Profiles
3
Malin Corporation has 3 current employee profiles, including Executive Sean Murphy
Executive
Executive
Employee

Exits

Malin Corporation has had 5 exits. Malin Corporation most notable exits include Kymab ,   Poseida Therapeutics

Date Company Name Exit Type Industry
Jan 11, 2021 Kymab M&A Biopharma Detail
Jul 9, 2020 Poseida Therapeutics IPO Biopharma Detail
Nov 27, 2019 3D4Medical.com M&A 3D Technology Detail
Nov 6, 2017 Melinta Therapeutics M&A Biotechnology Detail
Sep 21, 2016 Novan IPO Biotechnology Detail

Acquisition

Malin Corporation has acquired 2 organizations. Their most recent acquisition was Altan Pharma on Jun 11, 2015. They acquired Altan Pharma for €34.50M.

Date Company Name
Industry Acquisition Type Price
Jun 11, 2015 Altan Pharma
Biotechnology acquisition € 34.50M Detail
Biotechnology acquisition Detail